Area of research
Immunology · Oncology
Research interest
Research interests include Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, and CAR-T cell therapy research.
An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy
Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy
Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines